Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D11AX18	ALMIRAL	G	Diclofenac sodium - 1% w/w	1% w/w	Gel	396,434 L.L
D11AX18	LABDIC RELIEF	G	Diclofenac sodium - 1%w/w, Methyl salicylate - 8%w/w, Menthol - 2%w/w		Gel	263,393 L.L
D11AX18	DILO	G	Diclofenac sodium - 8%	8%	Spray	502,981 L.L
D11AX16	FLOREXA	G	Eflornithine (HCl) - 11.5%	11.5%	Cream	3,527,587 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
D11AX10	FINJUVE	G	Finasteride - 2.275mg/ml	2.275mg/ml	Spray, solution	6,708,462 L.L
D11AX01	ALOPEXY	G	Minoxidil - 20mg/ml	2%	Solution	532,162 L.L
D11AX01	ALOPEXY	G	Minoxidil - 2%	2%	Solution	532,162 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 2%	2%	Solution	2,839,539 L.L
D11AX01	ALOPEXY	G	Minoxidil - 50mg/ml	5%	Solution	896,343 L.L
D11AX01	ALOPEXY	G	Minoxidil - 5%	5%	Solution	896,343 L.L
D11AX01	HAIRGAINE 5	G	Minoxidil - 5%	5%	Solution	1,963,354 L.L
D11AX01	HAIRGROW	G	Minoxidil - 5%	5%	Solution	1,061,636 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 5%	5%	Solution	3,675,409 L.L
D11AX01	REGAINE FOAM FOR MEN	B	Minoxidil - 5%		Foam	1,370,719 L.L
D11AX01	REGAINE FOAM FOR MEN	B	Minoxidil - 5%		Foam	3,090,838 L.L
D11AX	TRIO-2000	G	Hydroquinone - 4%, Tretinoin - 0.05%, Hydrocortisone acetate - 1%		Ointment	2,495,068 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 300mg	300mg	Injectable solution	123,001,362 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 300mg	300mg	Injectable solution	123,001,362 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
D11AH02	ELIDEL	B	Pimecrolimus - 10mg/g	1%	Cream	1,780,591 L.L
D11AH01	PROTOPIC	B	Tacrolimus monohydrate - 0.1%	0.1%	Ointment	2,127,303 L.L
D11AH01	TACRUS	G	Tacrolimus monohydrate - 0.1%	0.1%	Ointment	1,857,190 L.L
D11AF	VERRUMAL	B	Fluorouracil - 0.5g/100g, Salicylic acid - 10g/100g		Solution	529,474 L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
D10BA01	A-CNOTREN	G	Isotretinoin - 20mg	20mg	Capsule, soft gelatin	1,468,376 L.L
D10BA01	CONTRACNE ISOTRETINOINE	G	Isotretinoin - 20mg	20mg	Capsule, soft	1,521,230 L.L
D10BA01	CURACNE	G	Isotretinoin - 20mg	20mg	Capsule, soft gelatin	1,603,204 L.L